Sensible Biotechnologies

Sensible Biotechnologies is a biotechnology company developing a cell-based platform for the design, optimisation, and manufacturing of high-quality mRNA.

Using engineered living cells and precision fermentation, the platform produces low-immunogenicity mRNA at scale, addressing fundamental limitations of conventional cell-free synthesis.

Sensible serves pharmaceutical and biotechnology partners developing mRNA therapeutics and vaccines, with ongoing partnerships with Ginkgo Bioworks, Sartorius Stedim Biotech, and NVIDIA.